INTRODUCTION
It is much easier and far less traumatic, as well as entirely non-invasive, to obtain faecal samples from study subjects, compared to blood samples. Faecal samples from a range of animal species can be easily provided by animal owners and breeders, or can be found in typical wildlife environments by experienced staff. Such samples are often collected for use in studies of diet composition or for the detection of gastrointestinal parasites by their faecal transmission stages [1, 2] . Thus, the relatively simple availability of faecal samples is greatly advantageous over the more tedious and traumatic collection of blood samples.
Vector-borne blood parasites, including protozoa from the Apicomplexa phyllum, constitute a serious health risk worldwide. One of the major aims of eco-epidemiological studies is the identification of the wildlife reservoirs of these parasites. These studies are often restricted due to the limited access to blood or tissue samples from wild animals. However, there is growing evidence that faecal sample can be used for the identification of blood parasite infections in different host species [3] [4] [5] . Many apicomplexan parasites affect the intestinal blood circulation of their hosts, leading to haemorrhagic events resulting in some blood losses into the gut lumen and hence gut contents [6, 7] . Thus, the presence of some blood and haemoparasites may be expected in faecal samples during infection. Moreover, current sensitive detection techniques based on the specific amplification of parasite DNA may enable detection of parasites, even in tiny amounts of blood-containing faeces. Cell-free parasite DNA, released from destroyed infected RBC (iRBC), may also contribute to the successful detection of blood parasites in faecal samples [8] .
In recent years, several studies have been published reporting the successful detection of blood parasite/pathogen DNA in faecal samples. These involved ground-breaking studies on the evolutionary origins of malaria parasites (Plasmodium spp.) conducted in free-living African apes [9] [10] [11] [12] . Other recent examples of successful detection of infections with important pathogens by analysis of faecal samples include HIV in chimpanzees [13] , Mycobacterium tuberculosis in humans [14] and Rickettsia spp. in humans [4] . In addition to Plasmodium spp., faecal samples were recently used for the detection of Trypanosoma brucei infections in wild chimpanzees from Africa [3] , and the detection of Babesia spp. in bat droppings in Hungary and the Netherlands [15] .
However, despite these positive reports, to the best of the knowledge of the authors of the current study, there is still a lack of basic studies assessing the sensitivity, specificity and reliability of faecal assays for the detection of blood parasites, and comparing the results from this methodology to conventional estimates of infection prevalence based on blood samples. Thus the present study was initiated in to compare the efficiency of detection of three Babesia species and Hepatozoon canis in blood and faecal samples from different host species, including samples derived from naturally infected red foxes Vulpes vulpes.
OBJECTIVES
The specific aims of the study were: 1) to assess the influence of phase of infection, during which parasitaemia levels can be expected to vary in intensity, on detectability of Babesia microti in experimentally infected mice; 2) to compare the detectability of Babesia spp. and H. canis in faecal samples by different PCR protocols: single-step and nested PCRs; 3) to compare detectability of parasite DNA in small and large volumes of faecal samples. On the basis of research hypothesis on the possibility of haemoparasite DNA detection in faecal samples, three predictions were made: 1) the success of detection should be higher during the acute phase of infection with high parasitaemia, than in the chronic phase of infection when there are very low levels of iRBC; 2) nested PCR protocols should be more sensitive than singlestep PCRs in detection of parasites in faecal samples; 3) detection of parasite DNA should be more successful in larger volumes of faecal sample, increasing the probability of successful DNA extraction.
MATERIALS AND METHOD
The origin of samples is provided in Table 1 . Three groups of hosts were involved. The first group of samples was obtained from nine laboratory mice Mus musculus (adult females, BALB/c strain) infected with B. microti King's 67 strain maintained in the authors' laboratory [16] . The animals came from a breeding facility run by the animal house of the Faculty of Biology at the University of Warsaw (breeders' register number 012). Mice were transferred to the experimental unit of the animal house. Each cage contained a layer of standard sawdust, water and standard food pellets ad libitum, together with bedding material (paper tubes). Females (3-5 in cage) were kept at a constant temperature of +18 °C, and with a 12 (Day): 12 (Night) light-dark phase.
To check the effect of parasitaemia on the success of DNA detection, three groups of three mice each were sampled at three time points: 1) during the acute phase following the first week of infection (on 6-7 days post infection, dpi) characterized by high parasitaemia up to 42-50% of iRBC (parasitaemia assessed, as described previously [16] ); 2) during the recovery period characterized by low parasitaemia of less than 5% (2.5-4.1% on 24-25 dpi in this study); 3) during the latent/chronic phase (on 66 or 68 dpi) characterized by very low parasitaemia (0.001% of iRBC in this study), when reliable detection of infection is only possible by PCR methodology [16] . These three separate groups were selected to enable comparison of the success of detection in faeces during different phases of B. microti infection, characterized by different levels of parasitaemia.
The infection procedures for B. microti have been described in detail previously [16, 17] . On the day of sampling, mice were first transferred individually to new clean cages for the collection of faecal samples. Faecal pellets were collected into sterile Eppendorf tubes using sterile forceps. The tip of the tail was cut with sterile scissors. A drop of blood was collected on a glass slide and a thin blood smear was made to enable microscopic examination for the presence of parasitaemia. Autopsies were then carried out under terminal isoflurane anesthesia. Blood samples (about 200 µl) were taken directly from the heart into 0.001 M EDTA (anticoagulant) and kept at a temperature of +4 °C before DNA extraction.
The second group of samples was derived from eight dogs that had presented to the veterinary clinic in the town of Tłuszcz near Warsaw (Central Poland) in autumn 2017 because they showed clinical symptoms of babesiosis, i.e. apathy, anorexia, fever, jaundice. Both faecal and blood samples were obtained from four symptomatic dogs, while only faecal samples (faecal swabs) were obtained from another four dogs with babesiosis. Blood samples were collected into sterile EDTA-covered vials (5 ml) and faecal samples were collected from the rectum into sterile faecal tubes (10 ml). Blood and faeces from another two Babesia-negative dogs (as tested in this study) were treated as negative controls for all procedures (DNA extraction and amplification). The third group of samples was obtained during our ongoing study on the role of red foxes as reservoir hosts of vector-borne blood parasites (Mierzejewska et al., unpublished). Fox carcasses were obtained from licensed hunters during the winter season of 2016/2017, and were first frozen at a temperature of -80 °C for two weeks before processing, to minimize the risk of contracting Echinococcus multilocularis infection during autopsies. Blood samples were obtained using sterile syringes, from the femoral vein, caudal vena cava or portal vein, placed into sterile vials (2 and 10 ml) and frozen at a temperature of -20 °C before DNA extraction. In the case of severe damages of the chest or heart, clotted blood was taken directly from the chest or abdominal cavity. Additionally, faecal samples were collected from the large intestine into sterile vials (20 or 50 ml) and frozen. Eleven infected foxes were selected for this study, including six foxes infected with B. vulpes, one infected with B. canis and four infected with H. canis.
Because the main aim of the present study was to evaluate the usefulness of faecal samples for detection of haemoparasites in wildlife, we compared two independent DNA extractions from fox faecal samples, using different amounts of faeces.
For the extraction of genomic DNA from all faecal samples the QIAamp PowerFaecal DNA kit (Qiagen, USA) was used. In this protocol, typical small amounts of faecal sample (up to 0.25 g) were used. For the additional extraction of genomic DNA from much larger amounts of faecal samples (5-10 g of faeces), the DNeasy PowerMax Soil kit (Qiagen, USA) we used. Faecal material from ten foxes was available for these double DNA extractions. Genomic DNA was extracted from murine, canine and fox blood samples using the DNeasy Blood & Tissue kit (Qiagen, USA) and stored at a temperature of -20 °C.
Molecular detection. Three procedures were selected for the PCR-based detection of parasites in blood and faecal samples. In the first procedure, a single-step PCR was applied, which is usually successful in the detection of parasite DNA in blood samples. Specific primers were used to amplify the 18S rRNA gene fragment of Babesia/Theileria (559 bp) [18, 19] or Hepatozoon [20] . Primers, primer source and annealing temperatures are listed in Table 2 . Reactions were performed in 1× PCR buffer, 1U DreamTaq polymerase, 1 μM of each primer and 2 μl of the extracted DNA sample. Negative controls were performed with 2 μl of sterile water, in the absence of template DNA.
The second procedure involved nested PCRs (Tab. 2). For the detection of Babesia spp. DNA, in the first step of a PCR, long fragments of 18S rDNA were amplified with apicomplexan 18S rRNA-specific primers: Crypto F and Crypto R [18, 19] . In the second step, the primers Bab GF/ Bab GR were used, as for the single-step PCR. To enhance detectability, secondary reactions were performed with different volumes of the first PCR product: 1 or 0.5 μl, or finally with 2 μl of a 1:9 dilution in sterile water. As positive controls, we used the genomic DNA of B. canis isolated from dog with canine babesiosis.
For the detection of Hepatozoon spp., DNA, in the first step of the PCR the full-length 18S rDNA was amplified with apicomplexan 18S rRNA-specific primers HAM 1F and HPF 2R [21] . In the second step the primers Hep F/ Hep R were used to amplify 666 bp fragment [20] .
As DNA of blood parasites in faecal samples may be degenerated, we applied also the third PCR protocol to amplify the short fragment (150 or 230 bp depending on species) of Babesia spp. mitochondrial DNA, lsu4-lsu5 [22] . For concurrent amplification of large (i.e. B. canis) and small babesiae DNA (i.e. B. microti or B. vulpes), three primers were used in this protocol ( Table 2) .
PCR reactions of each protocol were performed three times: samples positive two or three times were classified as positive; samples positive once or negative during three repetitions were classified as negative.
PCR products were subjected to electrophoresis on a 1.5% agarose gel stained with Midori Green stain (Nippon Genetics, GmbH). Selected nested PCR products obtained from blood samples and the majority of PCR products obtained from faecal samples (selected products obtained from murine samples and all products obtained from canine and fox samples) were sequenced by a private company (Genomed S.A., Poland). DNA sequence alignments and analyses were conducted using MEGA v. 7.0. Consensus sequences were compared with sequences deposited in the GenBank database using BioEdit tool (http://www.ncbi.nlm.nih.gov/genbank/).
RESULTS
Detection of parasite DNA from blood samples. All procedures were successful in amplifying parasite DNA from blood samples. Babesia microti was detected in nine experimentally infected mice; B. canis was detected in four dogs with babesiosis, while two control dogs yielded negative Table 3 .
Hepatozoon canis.
No positive results of any procedures were obtained for faecal samples from the H. canis-positive foxes.
Babesia spp. Overall, positive results of PCRs (appearance of the product of correct size in at least two separate reactions of at least one procedure) were obtained for all nine experimentally infected mice (9/9=100%), five dogs (5/8=62.5%) and four of seven foxes (57.1%) and none of two Babesia-negative dogs. PCR products were successfully sequenced for all selected murine samples (6/6=100%, all sequences identical with the reference B. microti strain), for four canine samples (one nested PCR product and three short lsu products; total 4/8=50%) and for only one fox sample (Tab. 3).
Two representative sequences of B. microti King's 67 strain obtained from murine faecal samples were deposited in GenBank database under accession numbers MH553358 (18S rDNA) and MH614921 (lsu). Obtained sequences were identical with B. microti sequences obtained from blood samples.
In three dog samples, the nested PCR signal was of sufficiently good quality to enable sequencing, but finally only one nested PCR product was successfully sequenced and displayed the highest similarity (507/508 bp=99.8%) to several B. canis sequences obtained from a Dermacentor reticulatus tick, a golden jackal or a European wolf (KT272401, KY747491, KY359360, respectively). However, the same four dogs were positive by the lsu protocol, and in this case all three sequenced products enabled identification of B. canis (100% similarity with GenBank Babesia canis canis KC207822 and 98% similarity with Babesia canis vogeli KC207825). Two of these sequences were deposited in the GenBank database under Accession Nos. MH580883 and MH580884. Babesia canis sequences were identical with sequences obtained from blood samples.
Among samples derived from infected foxes, only one sample (fox No. 146) was consistently positive by both extraction protocols in all applied procedures, and in this case the sequences were obtained for both sequenced nested PCR products. These proved to be identical to B. vulpes (B. cf. microti, B. annae; reclassified as B. vulpes by Baneth et al. 2015 [23] ) from red foxes from different European countries (KT233483, KT580785, KM115977) and an isolate from a dog (Babesia 'Spanish dog', AY457974). The sequence was deposited in the GenBank database under Accession No. MH553357, and was identical with the sequence obtained from the blood sample of this fox.
Short sequence of lsu also enabled identification of B. vulpes in a faecal sample from fox No. 146 (100% similarity with Babesia cf. microti KC207827 and 95% similarity with B. microti strain RILN871600), and this was also deposited in the GenBank under Accession No. MH614920.
The sequencing of nested PCR products from other fox samples was unsuccessful. Thus, the overall success of PCR detection of Babesia spp. in faecal samples of foxes based on sequencing results was much lower: 1/7=14.3%. No positive results were obtained for two control uninfected canine faecal samples. gen fragment or in the one-step PCR with Bab GF/Bab GR primers (Tab. 3).
Comparison of PCR protocols for detection of parasite

Comparison of detection of parasites between two DNA extraction protocols.
A higher number of positive samples was obtained for genomic DNA extracted from small amounts of faecal sample (n=4), in comparison to two positive samples obtained from genomic DNA extracted from the larger amounts of faecal sample (Tab. 3). However, the difference could not be statistically assessed due to the small number of compared samples. 
Comparison
DISCUSSION
The presented study compared the detection success of three Babesia species and H. canis in blood and faecal samples of different host species, including samples derived from naturally infected red foxes. Detection of H. canis in faecal samples was unsuccessful; however, all three species of Babesia were detected successfully in faecal samples. Extraction of genomic DNA from small amounts of faecal material combined with nested PCR revealed the highest number of positive samples.
The key finding of this study is that B. microti, B. vulpes and B. canis DNA can be detected successfully in faeces of infected hosts, in contrast to H. canis DNA which cannot be detected. This difference may stem from many different reasons, including different localization of H. canis in a host (neutrophils, not RBC) or different pathogenicity of H. canis infections in comparison to Babesia spp. Although H. canis infections in dogs are often asymptomatic [24] , no such data are available for foxes. Nevertheless, the very high prevalence of H. canis in fox populations in Central Europe [25] [26] [27] [28] , including Poland (up to 60%; Mierzejewska, unpublished) may support the low pathogenicity of this parasite for its natural hosts. On the other hand, B. canis infections constitute a serious health problem for dogs in Central Europe and Poland, contributing often to multiorgan complications and death [6, [29] [30] [31] . Babesia vulpes infections, however, are wide-spread among fox populations in Europe and the impact of this parasite, including its pathogenicity on fox health, has not been recognized todate [32] . Thus the detectability of Babesia spp. in faeces may depend less on the actual species of pathogen being assessed, than on its pathological consequences for the host and the degree to which it is likely to cause some blood losses into the intestine and faeces.
The sensitivity of detection of Babesia spp. in faecal samples in the study differed between host species, and was lower in naturally infected hosts in comparison to experimentally infected mice. The BALB/c mice used for experimental infection originated from a laboratory-bred colony, and to some degree the success of detection of B. microti may be attributable to the lack of other infections with intestinal protozoan parasites, including other apicomplexans. As can be seen from sequencing results for some PCR products, there was some non-specific amplification of other protozoan DNA is samples from dogs and foxes, i.e. Isospora, Dictyamoeba or other organisms (not presented), likely confounding the attempts to specifically amplify Babesia DNA. The sensitivity of T. brucei detection in faecal samples has also been found to differ between experimentally and naturally infected hosts [3] . In experimentally infected mice, as in the current study, the detection success was 100%, but T. brucei DNA was identified in only three of 13 tested faecal samples from wild chimpanzees.
It is difficult to evaluate the usefulness of the detection of Babesia spp. DNA in faecal samples from naturally infected hosts (dogs, foxes). The success of detection varied regarding the sequencing results obtained: combined sensitivity and specificity was 14% in foxes and 50% in dogs. On the other hand, the sequences obtained were of very good quality, and not different from sequences obtained from blood samples, enabling species identification. Widely available detection techniques (commonly used commercial DNA extraction kits, PCR and nested PCR) were intentionally selected to test if this method can be widely used for monitoring. On the basis of the results obtained, it can concluded that this method can be of use in the monitoring of Babesia infection in populations from which blood samples are hard to obtain; but importantly, the estimation of prevalence can be largely biased and underestimated. In the study of Siregar et al. [5] , several nested PCR protocols were evaluated for the detection of Plasmodium in macaque faeces. Although specificity of the implemented primers set was very high (100%), sensitivity varied between 23-29% for the cytochrome b gene, and 97% for mitochondrial small subunit rRNA (ssrRNA) gene fragment amplification [5] . Additionally, the same authors analyzed the sensitivity of methods used for the detection of Plasmodium DNA in faecal samples, as reported in other published papers, and again, depending on the PCR protocol and target, sensitivity/detectability differed profoundly from 20-30%, through 50-60% (both in the range of the current study), up to several studies reporting very high sensitivity of about/above 90% in faecal samples [5] .
In the presented study, the first evaluation of detectability of Babesia spp. and H. canis in faecal samples was provided, and the results largely concur with those from similar studies on Plasmodium. To verify whether large amounts of faeces facilitate better detection of blood parasites or if detectability depends on the phase of infection, further quantitative studies on more samples from animals infected with identified haemoparasites are needed.
